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Abstract 
Yeast major adenylate kinase (Aky2p), encoded by a single gene, occurs in two subcellular compartments, mitochondria nd 
cytoplasm. Only 6-8% of the protein which has no cleavable presequence is imported into the organelle (Bandlow et al. (1988) Eur. J. 
Biochem. 178, 451-457). In the wild type two AKY2-derived signals (a major and a minor one) were detected by a monospecific 
antibody after two-dimensional gel electrophoresis and Western blotting. The signals reflected identical electrophoretic mobilities and 
were absent from an AKY2-disrupted strain suggesting that they were due to differently modified forms of Aky2p. Two similar signals 
were found in a mutant defective in protein N-acetylation, however, the pI  values of both spots were shifted towards alkaline pH by one 
charge. This indicated that both forms of Aky2p were N-acetylated in the wild type and that their charge difference was not caused by 
incomplete N-acetylation. This observation furthermore suggested that, in the wild type, two different modifications exist one of which is 
N-acetylation. The second modification remains unidentified. We analysed the influence of protein N-acetylation on mitochondrial 
import. Both versions of Aky2p occurred in the cytoplasm and in mitochondria. Their proportion was unchanged in the N-acetylation 
mutant showing that neither modification affected the efficiency of import of adenylate kinase into mitochondria. It is discussed that 
N-acetylation occurs during or immediately after translation i the cytoplasm so that import of adenylate kinase may ensue co-translation- 
ally. 
Keywords: ATP:AMP phosphotransferase; Protein N-acetylation; N-terminal processing; Two-dimensional gel electrophoresis; Co-translational import; 
Mitochondrion; ( S. cereL'isiae) 
1. Introduction 
Adenylate kinases (EC 2.7.4.3) are abundant cellular 
proteins which provide the ADP required for oxidative and 
substrate chain phosphorylations and fulfill a very impor- 
tant role in the maintenance of the energy charge. Similar 
to the adenylate kinase in liver cells, the major ATP:AMP 
phosphotransferase in yeast, Aky2p, is a so-called ' long- 
form' isozyme [1,2]. It has an extraordinary subcellular 
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distribution. In yeast, more than 90% of the protein is 
located in the cytoplasm (and in the nucleus), and only the 
remainder of 6 to 8% resides in the mitochondrial inter- 
membrane space [3]. Aky2p lacks a cleavable presequence 
and is active in both compartments [3]. In contrast to 
Aky2p, all other known mitochondrial proteins are im- 
ported into mitochondria very efficiently with undetectably 
small precursor pools in the cytoplasm. Most precursors 
reach their sub-mitochondrial destination with the help of a 
cleavable targeting sequence. Sorting of proteins to the 
mitochondrial intermembrane space can occur on one of 
two alternative routes. Cytochromes b 2 and c 1, for in- 
stance, have twopartite presequences, the N-terminal part 
of which is required and sufficient for recognition of outer 
membrane receptors and the passage across both mem- 
branes. The N-terminal part of the topogenic sequence is 
removed by the matrix processing peptidase. The import of 
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these proteins requires a membrane potential over the inner 
membrane. It is still unclear, whether the second part of 
the presequence, which is cleaved off by a peptidase 
located in the intermembrane space, serves as a signal for 
re-export from the matrix [4] or as a stop-transfer signal 
preventing traversion of the inner membrane [5]. Other 
intermembrane space proteins like cytochrome c haem 
lyase [6] and presumably Aky2p take a direct route of 
import. They do not have a cleavable prepiece and do not 
require a membrane potential. However, cytochrome c
haem lyase is imported very efficiently, whereas most of 
Aky2p is located outside the organelle in the cytoplasm. 
So far, no internal mitochondrial target sequences have 
been identified in adenylate kinase. 
The following modifications have been reported to oc- 
cur on Aky2p: the N-terminal two amino acids, Met and 
Ser, are clipped off, and the N-terminus of the mature 
protein, Ser #3, is blocked by N-acetylation [2]. In addi- 
tion, an Asn residue has been shown convincingly to form 
the C-terminus [2], although an Asp is encoded by the gene 
sequence [7-9]. In the present study we investigated if we 
could detect these differently modified forms of Aky2p 
and analysed in particular, if any of the different versions 
of Aky2p preferentially occurs in one of the different 
subcellular compartments so that the type of modification 
has implications on mitochondrial import and topology of 
Aky2p. For this purpose we used high resolution two-di- 
mensional polyacrylamide g l electrophoresis [10] in com- 
bination with Western blot analysis. Since very little is 
known about he process of import of adenylate kinase into 
mitochondria, this approach might give some indication in 
the direction of either a post- or a co-translational translo- 
cation mechanism. 
2. Materials and methods 
2.1. Yeast strains, growth conditions, cellular subfraction- 
ation and enzyme assays 
The Saccharomyces cerevisiae wild type strain DL1 
MATa, his3-11, 15, leu2-3, 112, ura3-251,372,328 [11] 
served as the parental strain for the construction of the 
aky2 deletion, DL1-D16 [12] and the multi-copy transfor- 
mants DL1-D16 [URA6] [12] and DL1-D16 [PAK3] [13], 
respectively. In addition, wild type W303-1A MATa, 
ade2-1, his3-11, 15, leu2-3, 112, ura3-1, trpl-1, canl-lO0 
[14] and the N-acetylation deficient mutant strain AMR1 
nat1, other markers isogenic to W303-1A [15], were used. 
DL1 and DL1-D16 strains were grown on semisynthetic 
media containing 2% galactose, W303 and AMR1 nat1 
were grown in complete medium (2 1, 30°C, with vigorous 
shaking) on 3% lactate. Cell homogenates were prepared 
by breakage of the cells with glass beads by vortexing 
5 X 1 min with intervals of cooling on ice for 1 min and 
subsequent centrifugation (2 x 5 min, 3000 X g, presence 
of 5 mM dithiothreitol and a cocktail of proteinase in- 
hibitors consisting of 350 /xM phenylmethylsulfonyl fluo- 
ride, 1 mM EDTA, 50 U/ml Trasylol and 0.6 /xg/ml 
Pepstatin). Mitochondria were prepared from lysed sphero- 
plasts (9500 X g pellet), purified by Percoll (Pharmacia, 
Freiburg; 28%) gradient centrifugation a d routinely tested 
for contaminating proteins from other compartments ac- 
cording to published procedures [3,16]. The 105000 X g 
(60 min, 4°C) supernatant was used as the cytoplasmic 
fraction. Aliquots of supernatant and mitochondria were 
frozen in buffer containing proteinase inhibitors and 5 mM 
dithiothreitol, stored at -70°C and thawed only once. 
Protein was determined as described [17]. 
2.2. Raising of anti-Aky2p antibodies in chicken 
Antibodies against yeast Aky2p were raised in chicken 
using oligo-His-tagged adenylate kinase as the antigen. 
The recombinant protein was expressed under the guidance 
of the bacterial tac fusion promoter from plasmid pQE8 
(Diagen, Hilden) and purified from bacterial ysates by 
one-step Ni2+-chelate column chromatography according 
to the protocol supplied by the manufacturer. Two chicken 
were immunized [18] with about 200 /zg of the homoge- 
nous recombinant protein per injection, using complete 
Freund's adjuvant for the first immunisation. Two boost 
injections with complete Freund's adjuvant were per- 
formed four and eight weeks after the first immunization. 
The polyclonal antibodies were prepared from the egg 
yolks by dextran sulfate precipitation [19]. 
2.3. Two-dimensional electrophoretic procedure 
Two-dimensional gels were prepared according to [20] 
using an immobilized pH-gradient (IPG) pH 4-7 for iso- 
electric focusing [21,22]. Two identical gels were prepared 
in each case. One of the gels was silver stained [23], the 
other one blotted onto Fluorotrans membrane (Pall, Dreie- 
ich) according to Ref. [24]. For detection of Aky2p in a 
Western blot, the polyclonal chicken anti-Aky2p antibody 
was used in a 1:2000 dilution in phosphate-buffered saline. 
26 kDa 
1 2 3 5 4 
Fig. 1. Western blot analysis of Aky2 protein detected by polyclonal 
antibodies raised in chicken. 10 /zg protein (lanes 1-4) and 60 /xg 
protein (lane 5) from yeast cell homogenates was electrophoretically 
separated by sodium dodecyl sulfate gel electrophoresis, transferred onto 
Nylon membrane and immuno-decorated. Lane 1, wild type strain DL1; 
lanes 2 and 5, aky2 disruption mutant, DL1-D16; lane 3, transformant 
strain DLI-D16 [PAK3]; lane 4, transformant s rain DL1-D16 [URA6]. 
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The detection system consisting of the secondary anti- 
chicken IgG enhancer, horse radish peroxidase-coupled 
protein A and chloronaphthol as the developer (Bio-Rad, 
Geretsried) was used according to the prescriptions of the 
supplier. 
3. Results 
Antibodies directed against Aky2p were raised in 
chicken and tested for cross-reactivity with other members 
of the adenylate kinase family in yeast (i.e., Pak3p, the 
GTP:AMP phosphotransferase of the mitochondrial matrix 
[12], and Ura6p, the cytoplasmic UMP/CMP/AMP phos- 
photransferase [ 12,25]). For this purpose homogenates from 
wild type strain, DL1, the AKY2-disrupted strain, DL1- 
D16, and the PAK3 and URA6 multi-copy transformant 
strains, DL1-D16 [PAK3] and DL1-D16 [URA6], respec- 
tively, were prepared and transferred onto Nylon mem- 
brane after sodium dodecylsulfate polyacrylamide g l elec- 
trophoresis. Aky2p was detected after immuno-decoration 
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Fig. 2. Two-dimensional e ectrophoresis and Western blot of yeast cell homogenates decorated with anti-Aky2p antibodies. Two identical samples 
containing 60 /xg of the proteins each were separated by isoelectric focusing in the first dimension and then by SDS electrophoresis in the second 
dimension. One gel was stained with AgNO 3 for identification of the total protein spots (panels A and B). The other gel specimen was electro-blotted, 
Ponceau S-stained and immuno-decorated with anti-Aky2p antibodies (panels C, D and E). Panels A and D, wild-type W303-1A; panels B and E, 
N-acetylation-deficient mutant strain AMR1; panel C, aky2 disruption mutant DL1-DI6. Large arrows point at anti-Aky2p-reactive proteins. Small arrows 
denote Ponceau S-stained proteins which were found in all three extracts at identical positions and marked with Indian ink in panels C, D and E. They 
serve as reference spots to demonstrate he p l  shift of Aky2p. The other spots reflect material detected in this position by Ponceau S staining in only one of 
the extracts. 
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using chicken anti-Aky2p as primary antibodies. Western 
blot analyses of the homogenates from the wild type 
revealed a single band corresponding to a protein with an 
apparent molecular mass of about 26 kDa (Fig. 1) which is 
slightly above the value deduced from the amino acid 
sequence [2]. The antiserum is specific and does cross-re- 
act neither with Ura6p nor Pak3p, even after massive 
overexpression f either of these latter homologous pro- 
teins (lanes 3 and 4). Also homogenates containing 10 /zg 
(lane 2) or 60 /zg (lane 5) of homogenate of the aky2 
disruption strain did not reveal any signal, excluding 
cross-reactivity of the serum with so far undetected closely 
related adenylate kinase isozymes or other polypeptides 
from yeast (see Section 4). 
Adenylate kinase lacks a cleavable mitochondrial pre- 
sequence, and nothing is known about internal targeting 
signal(s) and the import mechanism of this protein. First 
we examined, whether isoforms of Aky2p exist and whether 
they exhibit differential uptake into the organelle. Indeed, 
two-dimensional gel electrophoresis (Fig. 2A) and Western 
blot analyses (Fig. 2D) of a homogenate of the wild type 
revealed two immuno-reactive spots of Aky2p. The major 
and the minor spots displayed identical electrophoretic 
mobilities and had isoelectric points (pl) of 6.2 and 5.9, 
respectively. The calculated isoelectric point of the unmod- 
ified protein deduced from the nucleotide sequence (pro- 
gram Isoelectric, UWGCG package) is at pH 6.37. Since in 
homogenates of the strain in which the AKY2 gene had 
been deleted no cross-reacting material is detectable in 
Western blot analysis (Fig. 2C), both signals must be 
derived from the single AKY2 gene. 
To examine, how the two spots are related to Aky2p 
and if the two forms of Aky2p differ by acetylation of the 
N-terminal amino acid, we compared the two-dimensional 
protein pattern from the wild type with that obtained with 
the homogenate of strain AMR1 natl. This mutant strain 
is deficient in N-acetyltransferase 1, the major N-acetyl- 
transferase, responsible for N-terminal protein acetylation 
[15]. The Western blot analysis of a natl extract also 
revealed two spots of Aky2p again with intensities compa- 
rable to the wild type (Fig. 2E). As shown by the silver- 
stained two-dimensional gels (compare Fig. Fig. 2A with 
Fig. 2B) as well as by using hexokinase as an intrinsic 
marker in Western blot analysis the pI of which was not 
affected by the natl mutation (not shown), both AKY2-de- 
rived spots were shifted to a more alkaline pH in compari- 
son to wild type Aky2p (pl values were 6.4 and 6.1, 
respectively). This clearly demonstrated that both isoforms 
were acetylated in the wild type and not acetylated in the 
mutant. Thus, the difference between the two isoforms of 
Aky2p in the wild type is not caused by incomplete 
N-acetylation. 
Next, we analysed, whether the minor spot is at- 
tributable to the version preferentially imported into mito- 
chondria and the major spot corresponds to the cytoplas- 
mic form. In addition, we tested if lack of N-acetylation i
the nat1 mutant strain excluded Aky2p from mitochondrial 
import. Fig. 3A shows that the nat1 mutant displays two 
spots in the cytoplasmic fraction which are the same as 
found in the homogenates, and the pI values of both 
isoforms are again shifted by one charge to alkaline pH in 
the N-acetylation-deficient strain relative to the NAT1 wild 
type (not shown, but compare Fig. 2D with Fig. 2E). The 
identical two forms occur also in mitochondria of the natl 
mutant strain (Fig. 3B) indicating that N-acetylation is 
neither specific for the cytoplasmic compartment, nor is it 
an indispensable prerequisite for mitochondrial import of 
Aky2p. It is concluded that this N-terminal modification 
does not prevent import, since the two isoforms occur at 
about the same proportion in both compartments. Further- 
more, N-acetylation is not applied intramitochondrially, 
i.e. after the protein has been imported, because the natl 
mutation simultaneously affects the pl  values of the cyto- 
plasmic and the mitochondrial version. Consequently, 
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Fig. 3. Two-dimensional Western blot of cytoplasmic (panel A) and mitochondrial proteins (panel B) from strain AMR1. 60 /xg of a high speed 
supernatant and mitochondria purified by Percoll gradient centrifugation [15], respectively, were tun in a two-dimensional gel, blotted onto Nylon 
membrane and proteins identified as described under Fig. 2 and reacted with anti-Aky2 antibodies. 
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NAT1 codes for a protein which acetylates both, cytoplas- 
mic and mitochondrial, forms of Aky2p. In addition, the 
results indicate that also the other modification either 
impedes nor promotes import of Aky2p into the organelle. 
A closer inspection of the silver-stained gels shown in 
Fig. 2A,B reveals that the spots, representing Aky2p iso- 
forms (large arrows), are shifted in the natl mutant strain 
relative to some major spots in the surrounding area which 
are not affected by the natl mutation (small arrows in Fig. 
2A-E). Consequently, the latter proteins are presumably 
not N-acetylated in either strain. In addition to Aky2p, a 
number of other spots are also shifted by about the same 
pH difference as each of the two isoforms of Aky2p. This 
observation allows to estimate, in line with the reports 
from higher eukaryotes [26], that also in yeast roughly 60 
to 80% of all proteins are N-acetylated by Natlp. Also the 
pl  values of a number of mitochondrial proteins differ in 
the two strains (data not shown). This finding demonstrates 
that, apart from the bulk of mitochondrial proteins which 
are processed at the N-terminus upon import into the 
organelle, some proteins exist, the pI values of which are 
affected by the deficiency in N-acetylation. These proteins 
obviously are not processed by the processing peptidase of 
the mitochondrial matrix (not shown here). Thus, the shift 
of pl  of a certain mitochondrial protein in a N- 
acetylation-deficient mutant may be used as a first screen 
for proteins lacking a cleavable mitochondrial targeting 
sequence. 
4. Discussion 
Most mitochondrial proteins are synthesized on free 
ribosomes in the cytoplasm. They are post-translationally 
targeted to the organelle by means of a cleavable prese- 
quence which is required and sufficient for both, recogni- 
tion of the mitochondrial surface receptor(s) and transloca- 
tion. The situation with Aky2p differs from this general 
scheme in several aspects: (i) Aky2p lacks a cleavable 
targeting sequence [3], (ii) only a minor fraction of Aky2p 
is imported into the organelle [3], (iii) the mitochondrial 
fraction of Aky2p does not equilibrate with a cytoplasmic 
pool prior to translocation, since it has been observed that 
some Aky2 mutant proteins are extremely unstable in the 
cytoplasm, but still are imported into mitochondria very 
efficiently (G. Strobel, R. Schricker and W. Bandlow, 
unpublished results), and (iv) the import efficiency can be 
improved by decreasing the stability of the protein struc- 
ture or by extending the time required by the protein to 
assume a folded structure which is likely to terminate the 
import-competent state [27]. These observations propose a 
co-translational mechanism of import of Aky2p in contrast 
to the bulk of mitochondrial proteins. Co-translational 
import is, indeed, discussed for at least a subset of mito- 
chondrial proteins [28-30]. The observation that mitochon- 
drial Aky2p is modified to the same extent as in the 
cytoplasmic fraction is consistent with a co-translational 
import mechanism only, when the modifications are ap- 
plied to the protein during translation. In fact, amino- 
terminal processing and N-acetylation of proteins are very 
rapid processes, and evidence has been obtained which 
implies that the acetyl group is attached to the polypeptide 
chain co-translationally [31,32]. The observation that in the 
NAT1 wild-type non-acetylated Aky2p is not detectable 
agrees with this view. The finding that the vast majority of 
wild-type Aky2p is excluded from import into mito- 
chondria suggests that an analogue of a recognition parti- 
cle and a translational rrest, to bring nascent Aky2p to the 
mitochondrial membrane, do not exist. A mechanism of 
uptake of Aky2p which is in agreement with the data 
presented here could be based on the kinetics of sponta- 
neous protein folding. In this model only those nascent 
Aky2 molecules are imported by mitochondria which are 
synthesized on ribosomes located in close proximity to the 
surface of the organelle and reach their cognate import 
receptors in an import competent state before tertiary 
structure formation commences. Such a mechanism im- 
plies that import and protein folding of adenylate kinase 
are competitive and mutually exclusive processes. 
In Western blot analyses of two-dimensional gels using 
a chicken antibody directed against recombinant His-tagged 
Aky2p two spots were detected. Both spots represent 
protein products of the single AKY2 gene, because these 
antibodies do not cross-react with other proteins in ho- 
mogenates of a strain in which the AKY2 gene had been 
deleted, even when an excess of protein was tested in 
Western blot analysis. The existence of further AMP ki- 
nases in addition to Ura6p [12] and Pak3p [13] is unlikely 
also for the following reasons: (i) In low stringency hy- 
bridization additional signals are absent, AKY2 is a single 
copy gene in the genome of Saccharomyces cerevisiae; (ii) 
in polymerase chain reactions on genomic DNA templates 
from an AKY2 deletion mutant using primers designed 
after conserved sequence blocks (ATP-binding site and 
DGF/YPR sequence) no amplification products were de- 
tected in addition to URA6 and PAK3; (iii) functional 
complementation tests of adenylate kinase deficiency, both 
in yeast and in E. coli, did not reveal complementing 
genes other than URA6 [12] and AKY3 [33]. 
Another possible explanation of the appearance of the 
two spots could be partial hydrolysis of the protein during 
preparation. However, (i) proteinase inhibitors were pre- 
sent throughout all steps of the preparation; (ii) aliquots of 
the samples were frozen immediately after preparation and 
thawed only once, and (iii) the coincidence of the elec- 
trophoretic mobility and the identical proportion of the two 
spots in homogenate, mitochondria and cytoplasm of two 
different strains argues against his possibility. 
Thus, the appearance of two versions of Aky2p is more 
likely due to an incomplete protein modification in addi- 
tion to N-acetylation. This modification alters the pl by 
one charge. Like N-acetylation it is also present both on 
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the cytoplasmic and the mitochondrially imported fraction 
of Aky2p. The nature of this additional modification has 
not yet been established. Both, the adenylate kinase protein 
[2] and the AKY2 gene [7-9] have been sequenced. The 
reading frame of the nucleotide sequence of AKY2 ends 
with a triplet encoding Asp, whereas it has been shown 
that the C-terminal amino acid of Aky2p is Asn. It is 
tempting to speculate that the second modification consists 
in the amidation of the C-terminal aspartic acid in agree- 
ment with the published protein sequence. This would 
imply that amidation is not quantitative. Indeed, the major 
isoform of Aky2p shown in Fig. 2A has a more alkaline 
pL Nothing is known about the kinetics and topology of 
protein amidation. The fact, that Aky2p is modified at the 
C-terminus, suggests a post-translational event. Such a 
mechanism is difficult to reconcile with co-translational 
import of Aky2p, but does not exclude this possibility. The 
concomitant occurrence of the modified and the unmodi- 
fied forms of Aky2p simultaneously in cytoplasm and 
mitochondria t about the same ratio could indicate that 
also this second modification is applied to the polypeptide 
before release from the ribosome although not to all 
molecules. 
Neither modification on Aky2p, N-acetylation or the 
other, not yet identified alteration, affects mitochondrial 
import indicating that neither has an influence on the 
velocity of tertiary structure formation. N-acetylation was 
found to increase the half-life of proteins considerably 
both in mitochondria and in the cytoplasm (data not shown). 
Presumably N-acetylation stabilizes the tertiary structure 
thereby rendering proteins more resistant to ubiquitination 
and subsequent degradation by the proteasome [34] in 
agreement with the N-end rule [35,36]. Indeed, we ob- 
served considerable degradation of Aky2p and other pro- 
teins in the nat1 mutant by contrast to the wild type. 
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